Alphatec Holdings, Inc. (ATEC)
| Market Cap | 1.24B -29.1% |
| Revenue (ttm) | 787.08M +22.5% |
| Net Income | -125.36M |
| EPS | -0.83 |
| Shares Out | 153.79M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,473,215 |
| Open | 7.70 |
| Previous Close | 7.66 |
| Day's Range | 7.70 - 8.24 |
| 52-Week Range | 6.82 - 23.29 |
| Beta | 0.97 |
| Analysts | Strong Buy |
| Price Target | 17.33 (+114.22%) |
| Earnings Date | May 5, 2026 |
About ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-o... [Read more]
Financial Performance
In 2025, Alphatec Holdings's revenue was $764.16 million, an increase of 24.95% compared to the previous year's $611.56 million. Losses were -$143.36 million, -11.57% less than in 2024.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for ATEC stock is "Strong Buy." The 12-month stock price target is $17.33, which is an increase of 114.22% from the latest price.
News
Alphatec Holdings Transcript: Bank of America Global Healthcare Conference 2026
Spine surgery market penetration remains low, but rapid growth is driven by clinical innovation, procedural adoption, and technology integration. International expansion and operational leverage have led to positive EBITDA, improved cash flow, and strong financial guidance for 2026.
Alphatec price target lowered to $24 from $27 at Barclays
Barclays analyst Matt Miksic lowered the firm’s price target on Alphatec (ATEC) to $24 from $27 and keeps an Overweight rating on the shares.
Alphatec price target lowered to $24 from $27 at Barclays
Barclays lowered the firm’s price target on Alphatec (ATEC) to $24 from $27 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q1…
Alphatec price target lowered to $23 from $25 at Canaccord
Canaccord lowered the firm’s price target on Alphatec (ATEC) to $23 from $25 and keeps a Buy rating on the shares. The firm said they posted an uncharacteristic miss in…
Alphatec price target lowered to $16 from $24 at JPMorgan
JPMorgan lowered the firm’s price target on Alphatec (ATEC) to $16 from $24 and keeps an Overweight rating on the shares.
Alphatec price target lowered to $11 from $20 at TD Cowen
TD Cowen lowered the firm’s price target on Alphatec (ATEC) to $11 from $20 and keeps a Buy rating on the shares. The firm said sales disappointed, particularly EOS, but…
Alphatec price target lowered to $15 from $25 at Lake Street
Lake Street analyst Ben Haynor lowered the firm’s price target on Alphatec (ATEC) to $15 from $25 and keeps a Buy rating on the shares. While “sell reflexes are strong…
Alphatec price target lowered to $14 from $25 at Needham
Needham analyst David b lowered the firm’s price target on Alphatec (ATEC) to $14 from $25 and keeps a Buy rating on the shares. The company’s Q1 results missed consensus…
Alphatec Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Alphatec Holdings, Inc. (NASDAQ: ATEC). The investigation focuses on Alphat...
Alphatec Holdings Earnings Call Transcript: Q1 2026
Q1 2026 revenue grew 14% year-over-year to $192 million, with surgical revenue up 17% and strong procedural and surgeon adoption. EOS revenue lagged due to installation delays, but guidance for 2026 remains robust, with 15% revenue growth and 17% surgical growth expected.
Alphatec Holdings Earnings release: Q1 2026
Alphatec Holdings released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Alphatec Holdings Slides: Q1 2026
Alphatec Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Alphatec Holdings Quarterly report: Q1 2026
Alphatec Holdings has published its Q1 2026 quarterly earnings report on May 5, 2026.
ATEC Reports First Quarter Financial Results
CARLSBAD, Calif--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced f...
ATEC Refinances Existing Debt with Inaugural Bank Facility
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced ...
Alphatec Holdings Proxy statement: Proxy filing
Alphatec Holdings filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.
Alphatec Holdings Proxy statement: Proxy filing
Alphatec Holdings filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.
ATEC to Report First Quarter 2026 Financial Results on May 5, 2026
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will r...
Alphatec assumed with an Overweight at Wells Fargo
Wells Fargo assumed coverage of Alphatec (ATEC) with an Overweight rating and $28 price target The firm is maintaining the current rating, price target and estimates.
Alphatec Holdings Transcript: Barclays 28th Annual Global Healthcare Conference
Strong growth and profitability were achieved through clinical distinction, surgeon adoption, and share gains amid industry disruption. Enabling technologies like the Valence robot support procedural integration, while disciplined capital deployment and efficient sales force expansion underpin continued confidence in future growth.
Alphatec price target lowered to $20 from $24 at Stifel
Stifel analyst Thomas Stephan lowered the firm’s price target on Alphatec (ATEC) to $20 from $24 and keeps a Buy rating on the shares. The firm updated models across its…
Alphatec Holdings Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 saw 20% and 25% revenue growth, respectively, with strong margin expansion and positive free cash flow. 2026 guidance was raised for both revenue and Adjusted EBITDA, driven by innovation, surgeon adoption, and operational leverage.
Alphatec Holdings Annual report: Q4 2025
Alphatec Holdings has published its Q4 2025 annual report on February 24, 2026.
Alphatec Holdings Earnings release: Q4 2025
Alphatec Holdings released its Q4 2025 earnings on February 24, 2026, summarizing the period's financial results.
Alphatec Holdings Slides: Q4 2025
Alphatec Holdings has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 24, 2026.